Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("ovarian cancer")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1575

  • Page / 63
Export

Selection :

  • and

Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell linesPRESNEAU, Nadège; MES-MASSON, Anne-Marie; BING GE et al.Oncogene (Basingstoke). 2003, Vol 22, Num 10, pp 1568-1579, issn 0950-9232, 12 p.Article

Inhibition of the antiproliferative effect of TGFβ by EGF in primary human ovarian cancer cellsDUNFIELD, Lesley Deanne; NACHTIGAL, Mark William.Oncogene (Basingstoke). 2003, Vol 22, Num 30, pp 4745-4751, issn 0950-9232, 7 p.Article

Phenoxodiol - an isoflavone analog - induces apoptosis in chemoresistant ovarian cancer cellsKAMSTEEG, Marijke; RUTHERFORD, Thomas; SAPI, Eva et al.Oncogene (Basingstoke). 2003, Vol 22, Num 17, pp 2611-2620, issn 0950-9232, 10 p.Article

Ovarian cancer : Can we make the clinical diagnosis earlier?SMITH, Lloyd H; MORRIS, Cyllene R; YASMEEN, Shagufta et al.Cancer. 2005, Vol 104, Num 7, pp 1398-1407, issn 0008-543X, 10 p.Article

High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: Long-term toxicity and outcomesFIRAT, Selim; MURRAY, Kevin; ERICKSON, Beth et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 1, pp 201-207, issn 0360-3016, 7 p.Article

Clinicopathologic analysis of early-stage sporadic ovarian carcinomaLEITAO, Mario M; BOYD, Jeff; HUMMER, Amanda et al.The American journal of surgical pathology. 2004, Vol 28, Num 2, pp 147-159, issn 0147-5185, 13 p.Article

Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype : results from the ovarian cancer association consortium pooled analysisPEARCE, C. L; WU, A. H; FREDERICKSEN, Z. S et al.British journal of cancer. 2008, Vol 98, Num 2, pp 282-288, issn 0007-0920, 7 p.Article

Epigenetic gene silencing in cancer initiation and progressionNEPHEW, Kenneth P; HUI-MING HUANG, Tim.Cancer letters. 2003, Vol 190, Num 2, pp 125-133, issn 0304-3835, 9 p.Article

The use of cytogenetics in understanding ovarian cancer : Ovarian and prostate cancersBERNARDINI, M; WEBERPALS, J; SQUIRE, J. A et al.Biomedicine & pharmacotherapy. 2004, Vol 58, Num 1, pp 17-23, issn 0753-3322, 7 p.Article

Role of BRCA1 in cellular resistance to paclitaxel and ionizing radiation in an ovarian cancer cell line carrying a defective BRCA1CHENYI ZHOU; SMITH, Janice L; JINSONG LIU et al.Oncogene (Basingstoke). 2003, Vol 22, Num 16, pp 2396-2404, issn 0950-9232, 9 p.Article

The Fas/Fas ligand system and cancer: Immune privilege and apoptosisABRAHAMS, Vikki M; KAMSTEEG, Marijke; MOR, Gil et al.Molecular biotechnology. 2003, Vol 25, Num 1, pp 19-30, issn 1073-6085, 12 p.Article

An intensity-region driven multi-classifier scheme for improving the classification accuracy of proteomic MS-spectraBOUGIOUKOS, Panagiotis; GLOTSOS, Dimitris; CAVOURAS, Dionisis et al.Computer methods and programs in biomedicine (Print). 2010, Vol 99, Num 2, pp 147-153, issn 0169-2607, 7 p.Article

Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment resultsTSERKEZOGLOU, Aliki; KONTOU, Sofia; HADJIELEFTHERIOU, George et al.Anticancer research. 2006, Vol 26, Num 3B, pp 2339-2344, issn 0250-7005, 6 p.Article

Whole abdominopelvic radiotherapy (WAPRT) using intensity-modulated arc therapy (IMAT): First clinical experienceDUTHOY, Wim; DE GERSEM, Werner; VERGOTE, Koen et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 4, pp 1019-1032, issn 0360-3016, 14 p.Article

Cost-Effectiveness of Combination Versus Sequential Docetaxel and Carboplatin for the Treatment of Platinum-Sensitive, Recurrent Ovarian CancerHAVRILESKY, Laura J; POKRZYWINSKI, Robin; REVICKI, Dennis et al.Cancer. 2012, Vol 118, Num 2, pp 386-391, issn 0008-543X, 6 p.Article

The Efficacy and Toxicity of Belotecan (CKD-602), a Camptothecin Analogue Topoisomerase I Inhibitor, in Patients with Recurrent or Refractory Epithelial Ovarian CancerKIM, Yong-Man; SHIN WHA LEE; KIM, Dae-Yeon et al.Journal of chemotherapy (Testo stampato). 2010, Vol 22, Num 3, pp 197-200, issn 1120-009X, 4 p.Article

Molecular genetic evidence that endometriosis is a precursor of ovarian cancerPROWSE, Amanda H; MANEK, Sanjiv; VARMA, Rajesh et al.International journal of cancer. 2006, Vol 119, Num 3, pp 556-562, issn 0020-7136, 7 p.Article

Treatment Decision-making Processes in the Systemic Treatment of Ovarian Cancer: Review of the Scientific EvidenceLUKETINA, Hrvoje; FOTOPOULOU, Christina; LUKETINA, Ruzica-Rosalia et al.Anticancer research. 2012, Vol 32, Num 9, pp 4085-4090, issn 0250-7005, 6 p.Article

Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathwaysDONNINGER, Howard; BONOME, Tomas; RADONOVICH, Mike et al.Oncogene (Basingstoke). 2004, Vol 23, Num 49, pp 8065-8077, issn 0950-9232, 13 p.Article

Interferon-γ expression is an independent prognostic factor in ovarian cancerMARTH, Christian; FIEGL, Heidi; ZEIMET, Alain G et al.American journal of obstetrics and gynecology. 2004, Vol 191, Num 5, pp 1598-1605, issn 0002-9378, 8 p.Article

Differences in symptoms between patients with benign and malignant ovarian neoplasmsATTANUCCI, Cara A; BALL, Harrison G; ZWEIZIG, Susan L et al.American journal of obstetrics and gynecology. 2004, Vol 190, Num 5, pp 1435-1437, issn 0002-9378, 3 p.Article

Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapyWU, H; HAN, T; LAM, J. T et al.Gene therapy (Basingstoke). 2004, Vol 11, Num 10, pp 874-878, issn 0969-7128, 5 p.Article

Cyclin E deregulation alters the biologic properties of ovarian cancer cellsBEDROSIAN, Isabelle; LU, Karen H; VERSCHRAEGEN, Claire et al.Oncogene (Basingstoke). 2004, Vol 23, Num 15, pp 2648-2657, issn 0950-9232, 10 p.Article

Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralizationHUDELIST, G; SINGER, C. F; KUBISTA, E et al.Histopathology. 2004, Vol 45, Num 6, pp 633-637, issn 0309-0167, 5 p.Article

Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expressionRANGEL, Leticia B. A; SHERMAN-BAUST, Cheryl A; WERNYJ, Roman P et al.Oncogene (Basingstoke). 2003, Vol 22, Num 46, pp 7225-7232, issn 0950-9232, 8 p.Article

  • Page / 63